Regulatory Innovation

FDA Town Hall

11:00 AM–12:00 PM Jun 5, 2018

Room 253ABC, Level 2


The session will be organized as an interactive, moderated roundtable discussion of FDA center priorities followed by a question-and-answer session with the audience.  Topics that will be addressed during the roundtable will include the FDA’s perspectives on critical topics such as PDUFA VI implementation; efforts to advance innovation and expedite patient access to novel therapies for serious and life-threatening conditions; novel approaches to integrating new scientific tools into FDA regulatory practices at all levels; and FDA resources and scientific infrastructure.  

Session ID: 361814